Leaflet NITROXOLINA-MIP 250mg soft capsules


Indicated for: bacterial infections

Route of administration: oral

Substance: nitroxoline (antibacterial antibiotic)

ATC: J01XX07 (Antiinfectives for systemic use | Other antibacterials)

Nitroxolinum is an antibiotic used to treat urinary tract infections caused by sensitive bacteria. This medication works by inhibiting bacterial DNA synthesis, thereby preventing the multiplication of pathogenic microorganisms.

Nitroxolinum is effective against a wide range of bacteria, including Escherichia coli, Proteus, and Klebsiella. It is primarily used for acute and chronic urinary tract infections, such as cystitis and pyelonephritis.

The drug is generally well-tolerated but may cause side effects such as nausea, vomiting, or allergic reactions. It is important to follow the prescribed dosage to avoid the development of bacterial resistance.

Nitroxolinum is not recommended during pregnancy or breastfeeding unless the benefits outweigh the risks. Consult your doctor before use.

General data about NITROXOLINA-MIP 250mg

  • Substance: nitroxoline
  • Date of last drug list: 01-05-2026
  • Commercial code: W59990003
  • Concentration: 250mg
  • Pharmaceutical form: soft capsules
  • Quantity: 90
  • Product type: generic
  • Price: 164.16 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: CHEPHASAAR GMBH - GERMANIA
  • Holder: MIP PHARMA GMBH - GERMANIA
  • Number: 5701/2013/03
  • Shelf life: 2 years

Pharmaceutical forms available for nitroxoline